You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Formulation information for generic ingredient: colistimethate sodium


✉ Email this page to a colleague

« Back to Dashboard


COLISTIN

CASRN: 1066-17-7

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing